Serina Therapeutics eliminates Series A Preferred Stock
- Filed Certificate of Elimination on Oct 5, 2026
- Removed Series A Convertible Preferred Stock designations
- All Series A Preferred Stock converted to common stock
Every EDGAR filing for Serina Therapeutics, Inc. (SER), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Farrell Simon, insider filing for SER
Farrell Simon, reporting
Ownership stake disclosure by Juvenescence Ltd (amended)
Juvenescence Ltd, filed by
Stephen K. Brannan, insider filing for SER
Stephen K. Brannan, reporting
Jay Venkatesan, insider filing for SER
Jay Venkatesan, reporting
Karen J Wilson, insider filing for SER
Karen J Wilson, reporting
Steven A Ledger, insider filing for SER
Steven A Ledger, reporting
Srini Tenjarla, insider filing for SER
Srini Tenjarla, reporting
Karen J Wilson, insider filing for SER
Karen J Wilson, reporting
Richard Peter Marshall, insider filing for SER
Richard Peter Marshall, reporting
Ownership stake disclosure by Sio Capital Management, LLC
Sio Capital Management, LLC, filed by
Gregory Bailey, insider filing for SER
Gregory Bailey, reporting
Randall Moreadith, insider filing for SER
Randall Moreadith, reporting
Randall Moreadith, insider filing for SER
Randall Moreadith, reporting
Randall Moreadith, insider filing for SER
Randall Moreadith, reporting
Randall Moreadith, insider filing for SER
Randall Moreadith, reporting